The Plasma Therapy Market Size was valued at USD 416.83 billion in 2022, and is expected to reach USD 836.69 billion by 2030, and grow at a CAGR of 9.1% over the forecast period 2023-2030.
Plasma, platelets, red blood cells, and white blood cells make up the blood. Plasma makes up over 57% of the entire blood volume. Important hormones, proteins, and nutrients are transported by the plasma to many bodily areas. The fundamental goal of plasma therapy is to give a patient access to a healthy person's immune. The plasma typically has a high concentration of antibodies, which aids in the treatment of the illness.
Get more information on Plasma Therapy Market - Request Sample Report
Proteins that are lacking or insufficient can be replaced by plasma treatment, enabling people to live healthy, disorder-free lives. Human blood provides various plasma-derived remedies for crippling, ongoing, and life-threatening illnesses as a result of expanding plasma-fractionation procedures. Plasma-derived products are essential for prevention and medical treatment. Plasma products are essential for treating autoimmune disorders, a variety of chronic illnesses such hemophilia, congenital and acquired immunodeficiencies, and bleeding emergencies. The market for plasma therapy is expanding as a result of improved access to healthcare, new goods and uses, and diagnostic advancements.
DRIVERS
Sports injuries are occurring more frequently.
Global Androgenic Alopecia Patient Numbers are on the Rise
Increasing Application of Platelet-Rich Plasma in a Variety of Therapeutic Fields
Arthritis frequency
RESTRAINTS
Absence of Policies for Reimbursement
Different Plasma Therapy Costs
OPPORTUNITIES
A rise in the number of people afflicted with orthopedic conditions and androgenic alopecia
CHALLENGES
Patients with diabetes and kidney diseases cannot use PRP without restrictions
Additional Regenerative Medicine Developments
The COVID-19 pandemic outbreak and government-ordered lockdowns to stop the disease's spread had an effect on a number of businesses. Due to the hospitals' inadequate staff and resources in comparison to the unexpected increase in the number of infected patients, the spike in infected patients had an influence on hospital administration. This resulted in a delay in medical treatments and surgeries. The non-emergency medical operation was postponed, and priority was given to emergency treatments that were more likely to impact patients or result in fatalities if postponed.
The plasma supply was put under further strain by the COVID-19 epidemic. The unexpected increase in COVID-19 patients has an impact on businesses, suppliers, and owners of platelet-rich plasma (PRP) therapeutic items in Asian economies. The absence of health infrastructure and government rules put on businesses and suppliers created problems for the middle- and low-income countries. Because there were no vaccines, other specialised medications, or treatments available during the pandemic, plasma therapy was suggested as a treatment.
By Type
Due to the minimal or nonexistent dangers associated with the use of pure PRP, the pure PRP category exhibits the biggest revenue share of the global market. Pure platelet-rich plasma is a preparation that has less red blood cells and concentrated platelet growth factors. It shows positive results in the treatment of patients' illnesses. The method is strongly advised.
Leukocyte-Rich PRP: PRP that is high in leukocytes is used to treat osteoarthritis in the hips and knees. A preparation with a high proportion of leukocytes is called leukocyte-rich PRP. Its primary purpose is to aid in the repair of ligaments and tendons.
Pure Platelet-Rich Fibrin: It's utilised to encourage wound healing, bone regeneration, transplant stabilization, and hemostasis. Platelet-rich fibrin and autologous leukocytes produced from patient blood can be used to define it.
Leukocyte-Rich Fibrin is an autologous platelet concentrate that has an increased fibrin matrix made up of platelets, leukocytes, and an excess of growth factors and cytokines.
By Source
Autologous: In 2021, this market category will hold the lion's share of the market. The market development of the autologous source segment is being driven by the widespread acceptance of plasma therapy as a potential treatment for bones and tissues in need of mending.
Allogenic: When compared to whole blood, allogeneic PRP contains 4.1 times as many platelets and growth regulators, respectively.
By Application
Dermatology: During the projection period, the segment is anticipated to have the greatest CAGR. This can be linked to an increase in the number of patients with hair- and skin-related disorders, a rise in the general public's awareness of beauty, and an increase in the usage of micro needling for cosmetic procedures.
Orthopedic: The market sector is expanding quickly due in large part to the increase in individuals suffering from bone-related illnesses such as arthritis. These disorders affect the bones and limbs.
Heart Muscle Injury: The cardiac muscles are treated using plasma. The repair of cardiac muscles is aided by plasma.
By End-users
Hospitals & Clinics: The treatment of illnesses like COVID-19, autoimmune disorders, cardiac-related ailments, and others is done in hospitals using plasma therapy.
Research Institutes: In order to develop a cure for common and dangerous diseases, research institutes use plasma from various patients.
By Type
Pure PRP
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
By Source
Autologous
Allogenic
By Application
Orthopedic
Cardiac Muscle Injury
Dental
Nerve Injury
By End-users
Hospitals & Clinics
Research Institutes
.png)
Need any customization research on Plasma Therapy Market - Enquiry Now
During the projection period, North America is anticipated to have a significant market share for plasma therapy worldwide. Due to increased government and private sector research and development, it is projected that the market in the region would expand in the future. Due to growing populations and increased public awareness of blood donation, Asia-Pacific is also expected to experience significant growth. The expansion of hospitals and clinics as well as the availability of cutting-edge plasma therapies fuel the plasma therapy market.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Major key players are as follows: Arthrex, Terumo Corporation, Exactech, Inc., Johnson & Johnson (DePuy Synthes), MTF Biologics, Ony Biotech Inc., Pfizer Inc., Regen Lab SA, Teva Pharmaceutical Industries Ltd., Zimmer Biomet and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 416.83 Billion |
| Market Size by 2030 | US$ 836.69 Billion |
| CAGR | CAGR of 9.1% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin) • By Source (Autologous, Allogenic) • By Application (Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury) • By End-users (Hospitals & Clinics, Research Institutes) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Arthrex, Terumo Corporation, Exactech, Inc., Johnson & Johnson (DePuy Synthes), MTF Biologics, Ony Biotech Inc., Pfizer Inc., Regen Lab SA, Teva Pharmaceutical Industries Ltd., Zimmer Biomet. |
| Key Drivers | • Sports injuries are occurring more frequently. • Global Androgenic Alopecia Patient Numbers are on the Rise. |
| RESTRAINTS | • Absence of Policies for Reimbursement • Different Plasma Therapy Costs |
Ans. The Plasma Therapy market size was valued at US$ 416.83 billion in 2022.
Ams: The Plasma Therapy market is to grow at a CAGR of 9.1% over the forecast period 2023-2030.
Ans The plasma supply was put under further strain by the COVID-19 epidemic. The unexpected increase in COVID-19 patients has an impact on businesses, suppliers, and owners of platelet-rich plasma (PRP) therapeutic items in Asian economies.
Ans. Arthrex, Terumo Corporation, Exactech, Inc., Johnson & Johnson (DePuy Synthes), MTF Biologics, Ony Biotech Inc., Pfizer Inc. are the key players of the Plasma Therapy Market
Ans. Dermatology During the projection period, the segment is anticipated to have the greatest CAGR.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Plasma Therapy Market Segmentation, By Type
8.1 Pure PRP
8.2 Leukocyte-Rich PRP
8.3 Pure Platelet-Rich Fibrin
8.4 Leukocyte-Rich Fibrin
9. Plasma Therapy Market Segmentation, By Source
9.1 Autologous
9.2 Allogenic
10. Plasma Therapy Market Segmentation, By Application
10.1 Orthopedic
10.2 Dermatology
10.3 Cardiac Muscle Injury
10.4 Dental
10.5 Nerve Injury
11. Plasma Therapy Market Segmentation, By End-users
11.1 Hospitals & Clinics
11.2 Research Institutes
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13.Company Profiles
13.1 Arthrex
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Terumo Corporation
13.3 Exactech, Inc.
13.4 Johnson & Johnson (DePuy Synthes)
13.5 MTF Biologics
13.6 Ony Biotech Inc.
13.7 Pfizer Inc.
13.8 Regen Lab SA
13.9 Teva Pharmaceutical Industries Ltd.
13.10 Zimmer Biomet
14.Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Track and Trace Solutions Market Size was valued at USD 3.51 billion in 2022, and is expected to reach USD 14.21 billion by 2030 and grow at a CAGR of 19.1% over the forecast period 2023-2030.
The Cell Separation Market size was estimated USD 9.06 billion in 2023 and is expected to reach USD 12.68 billion by 2031 at a CAGR of 9.95% during the forecast period of 2024-2031.
The Digital Radiology Rarket was estimated at USD 12.19 billion in 2022 and is projected to reach USD 22.40 billion by 2030, developing at a CAGR of 7.9% from 2023 to 2030.
The Healthcare BPO Market Size was valued at USD 360.36 billion in 2023 and is expected to reach USD 767.40 billion by 2031 and grow at a CAGR of 9.91% over the forecast period 2024-2031.
The Vitamin D Testing Market Size was valued at USD 6.70 billion in 2022 and expected to reach USD 9.98 billion by 2030, and grow at a CAGR of 5.1% over the forecast period 2023-2030.
The Sleep Disorder Treatment Market size was valued at US$ 9.2 billion in 2022 and is projected to reach US$ 18 billion by 2030, with a growing CAGR of 8.7% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
